Clinical Trial Update: Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

A long-term safety study (Phase 2/3) evaluated alogliptin used in combination with an α-glucosidase inhibitor in Japanese participants with Type 2 Diabetes Mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (Nesina) (alogliptin)
• acarbose (Precose) (acarbose)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-08-29